Literature DB >> 908425

The chemokinetic effect of serum albumin.

H U Keller, M W Hess, H Cottier.   

Abstract

Experiments performed by means of time lapse cinematography or the filter technique show that human serum albumin has marked chemokinetic effects on neutrophil cultured in Gey's solution. The average speed of the cells, as well as the proportion of neutrophils showing locomotion, is increased. Enhanced locomotion correlates with decreased attachment to the substratum as determined by morphological and functional criteria.

Entities:  

Mesh：

Substances：

Year:  1977        PMID： 908425     DOI： 10.1007/bf01920196

Source DB:  PubMed          Journal:  Experientia        ISSN： 0014-4754


  8 in total

1.  A requirement for albumin as carrier for low molecular weight leukocyte chemotactic factors.

Authors:  P C Wilkinson
Journal:  Exp Cell Res       Date:  1976-12       Impact factor: 3.905

2.  A proposal for the definition of terms related to locomotion of leucocytes and other cells.

Authors:  H U Keller; P C Wilkinson; M Abercrombie; E L Becker; J G Hirsch; M E Miller; W Scottramsey; S H Zigmond
Journal:  Clin Exp Immunol       Date:  1977-03       Impact factor: 4.330

3.  Cell-substrate adhesivity. A determinant of cell motility.

Authors:  M H Gail; C W Boone
Journal:  Exp Cell Res       Date:  1972-01       Impact factor: 3.905

4.  Studies on chemotaxis. 3. Modification of Boyden's technique for the evaluation of chemotactic agents.

Authors:  H U Keller
Journal:  Immunology       Date:  1966-03       Impact factor: 7.397

5.  Permanent fixation of lymphoid cells exposed to dye exclusion test.

Authors:  M H Claesson; P E Hoyer; C Ropke
Journal:  Scand J Haematol       Date:  1969

6.  Effects of migration inhibiting factor(s) on the in vitro detachment of macrophages.

Authors:  L Weiss; D Glaves
Journal:  J Immunol       Date:  1975-11       Impact factor: 5.422

7.  Studies on the regulation of the neutrophil chemotactic response using a rapid and reliable method for measuring random migration and chemotaxis of neutrophil granulocytes.

Authors:  H U Keller; H Gerber; M W Hess; H Cottier
Journal:  Agents Actions       Date:  1976-02

8.  Leukocyte locomotion and chemotaxis. New methods for evaluation, and demonstration of a cell-derived chemotactic factor.

Authors:  S H Zigmond; J G Hirsch
Journal:  J Exp Med       Date:  1973-02-01       Impact factor: 14.307
  8 in total
  8 in total

1.  Kinetics of chemo-attraction of polymorphonuclear leukocytes towards N-formyl peptide studied with a novel polycarbonate (Nucleopore) membrane in the Boyden chamber.

Authors:  L P Bignold
Journal:  Experientia       Date:  1988-06-15

Review 2.  Physiology of granulocyte locomotion and its relation to defects of chemotaxis: a review.

Authors:  P C Wilkinson
Journal:  J R Soc Med       Date:  1979-08       Impact factor: 5.344

3.  Chemotaxis is not a special case of haptotaxis.

Authors:  H U Keller; J H Wissler; J Ploem
Journal:  Experientia       Date:  1979-12-15

4.  Attachment of human C5a des Arg to its cochemotaxin is required for maximum expression of chemotactic activity.

Authors:  H D Perez; D E Chenoweth; I M Goldstein
Journal:  J Clin Invest       Date:  1986-12       Impact factor: 14.808

5.  A specific inhibitor of complement (C5)-derived chemotactic activity in serum from patients with systemic lupus erythematosus.

Authors:  H D Perez; M Lipton; I M Goldstein
Journal:  J Clin Invest       Date:  1978-07       Impact factor: 14.808

6.  Comparison of adhesion to glass and aggregation of human leucocytes.

Authors:  B Damerau; H U Keller
Journal:  Agents Actions       Date:  1983-02

7.  Chemokinesis of rat polymorphonuclear leucocytes and the effect of cyclic adenosine 3',5'-monophosphate.

Authors:  D Bradshaw; J P Giroud; M Roch-Arveiller
Journal:  Br J Pharmacol       Date:  1980-04       Impact factor: 8.739

8.  Identification of the C5a des Arg cochemotaxin. Homology with vitamin D-binding protein (group-specific component globulin).

Authors:  H D Perez; E Kelly; D Chenoweth; F Elfman
Journal:  J Clin Invest       Date:  1988-07       Impact factor: 14.808
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.